Format

Send to

Choose Destination
Front Physiol. 2016 Jan 12;6:406. doi: 10.3389/fphys.2015.00406. eCollection 2015.

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy.

Author information

1
Computational Genomics, National Institute of Genomic MedicineMéxico City, Mexico; Complejidad en Biología de Sistemas, Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de MéxicoCiudad de México, Mexico.
2
Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro Querétaro, Mexico.
3
Departamento de Química Inorgánica y Nuclear, Facultad de Química, Universidad Nacional Autónoma de México Ciudad de México, Mexico.

Abstract

The understanding of the mechanisms associated with the action of chemotherapeutic agents is fundamental to assess and account for possible side-effects of such treatments. Casiopeínas have demonstrated a cytotoxic effect by activation of pro-apoptotic processes in malignant cells. Such processes have been proved to activate the apoptotic intrinsic route, as well as cell cycle arrest. Despite this knowledge, the whole mechanism of action of Casiopeínas is yet to be completely understood. In this work we implement a systems biology approach based on two pathway analysis tools (Over-Representation Analysis and Causal Network Analysis) to observe changes in some hallmarks of cancer, induced by this copper-based chemotherapeutic agent in HeLa cell lines. We find that the metabolism of metal ions is exacerbated, as well as cell division processes being globally diminished. We also show that cellular migration and proliferation events are decreased. Moreover, the molecular mechanisms of liver protection are increased in the cell cultures under the actions of Casiopeínas, unlike the case in many other cytotoxic drugs. We argue that this chemotherapeutic agent may be promising, given its protective hepatic function, concomitant with its cytotoxic participation in the onset of apoptotic processes in malignant cells.

KEYWORDS:

Casiopeína II-gly; causal network analysis; copper-based chemotherapy; liver protection; systems pharmacology

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center